Show simple item record

dc.contributor.authorVieira, Fabiola Sulpinoes_ES
dc.date.accessioned2015
dc.date.available2015
dc.date.issued2010es_ES
dc.identifier.citationVieira, Fabiola Sulpino (2010) Assistência farmacêutica no sistema público de saúde no Brasil. Rev Panam Salud Publica;27(2) 149-156,fev. 2010. Retrieved from http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892010000200010pt_BR
dc.identifier.urihttp://www.scielosp.org/scielo.php?script=sci_arttext&pid=S1020-49892010000200010es_ES
dc.identifier.urihttps://iris.paho.org/handle/10665.2/9716
dc.relation.ispartofseriesRev Panam Salud Publica;27(2),feb. 2010es_ES
dc.subjectPolítica Nacional de Assistência Farmacêuticapt_BR
dc.subjectAssistência Farmacêuticapt_BR
dc.subjectFinanciamento da Assistência à Saúdept_BR
dc.subjectMedicamentoses_ES
dc.subjectBrasilpt_BR
dc.subjectNational policy of pharmaceutical assistancees_ES
dc.subjectPharmaceutical assistancees_ES
dc.subjectFinancing, Healthes_ES
dc.subjectPharmaceutical preparationses_ES
dc.subjectBrazilen_US
dc.subjectAssistência Farmacêuticapt_BR
dc.subjectPrática de Saúde Públicapt_BR
dc.subjectBrasilpt_BR
dc.titleAssistência farmacêutica no sistema público de saúde no Brasilpt_BR
dc.typeJournal articlesen_US
dc.rights.holderPan American Health Organizationen_US
dc.description.notesThis article deals with the organization of pharmaceutical assistance within the Brazilian Public Unified Health System (Sistema Único de Saúde, SUS) by analyzing the progress made so far and the challenges that still must be faced to ensure the right to universal therapeutic and pharmaceutical coverage in Brazil. Among the improvements, the article discusses the National List of Essential Drugs and its role to guide the supply, prescription, and dispensing of drugs within SUS. The structure of federal funding and the existing pharmaceutical programs are described, as well as the responsibilities of the Federal Government, states, and municipalities concerning allocation of financial resources. Despite the progress made, the model of access to SUS drugs has not been successful in securing universal therapeutic assistance. It is essential to consider a type of funding and organization of pharmaceutical assistance that is driven by a notion of regionalization, with financing based on health care flows rather than on the population circumscribed to a given territory. It is also essential to qualify pharmaceutical management by hiring pharmacists and support personnel, professionalizing workers, and setting up facilities with appropriate information systems and equipment.(AU)en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record